Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Hematopoietic Cell Transplantation (HCT) Is an Effective Treatment for Blastic Plasmacytoid Dendritic Cell Neoplasm: Systematic Review and Meta-Analysis Assessing the Role of Allogeneic and Autologous HCT

Razan Mohty, Hemant S. Murthy, Tea Reljic, Katelyn Keller, Ambuj Kumar, Mohamed A. Kharfan-Dabaja

Blood (2024) 144 (Supplement 1): 7906.

https://doi.org/10.1182/blood-2024-204306

Published: 2024

Journal Articles

Outcomes and Clinical Characteristics of Adult Patients with Transplant Associated Thrombotic Microangiopathy: A Single Center Experience

Manuel Espinoza-Gutarra, Omer Jamy, Razan Mohty, Lauren Kelly Shea, Donna Salzman, Antonio Di Stasi, Ravi Bhatia, Zaid Al-Kadhimi, Sumithira Vasu

Blood (2024) 144 (Supplement 1): 7290.

https://doi.org/10.1182/blood-2024-206687

Published: 2024

Journal Articles

Superior Survival with Intensive Chemotherapy, Compared to Hypomethylating Agent + Venetoclax, in Patients with Intermediate/Adverse Risk Acute Myeloid Leukemia Unable to Proceed to Transplant

Kendall Diebold, Todd Mudd, Jay Jarodiya, Katherine Parks, Maris Hardee, Kimo Bachiashvili, Sravanti Rangaraju, Pankit Vachhani, Manuel Espinoza-Gutarra, Razan Mohty, Ravi Bhatia, Omer Jamy

Blood (2024) 144 (Supplement 1): 2900.

https://doi.org/10.1182/blood-2024-204120

Published: 2024

Journal Articles

Effect of Lumbar Puncture Timing on Neurotoxicity with Blinatumomab Therapy in a Real-World Cohort of Acute Lymphoblastic Leukemia (ALL)

Sravanti Rangaraju, Kendall Diebold, Pankit Vachhani, Omer Jamy, Kimo Bachiashvili, Ravi Bhatia, Razan Mohty, Manuel Espinoza-Gutarra, Joshua Oliver, Barry Diamond, Kaitlin Moulton, Zaid Al-Kadhimi

Blood (2024) 144 (Supplement 1): 2808.

https://doi.org/10.1182/blood-2024-211985

Published: 2024

Journal Articles

Applying the Novel EHA/EBMT Grading System for Icaht Following CAR-T Therapy: Comparative Incidence across Disease Entities and Association with Infections and Mortality

Kai Rejeski, Doris K. Hansen, Yucai Wang, Gloria Iacoboni, Emmanuel Bachy, Radhika Bansal, Olaf Penack, Fabian Mueller, Wolfgang Andreas Bethge, Javier L. Munoz, Razan Mohty, Veit L. Buecklein, Pere Barba, Frederick L. Locke, Yi Lin, Michael D. Jain, Marion Subklewe

Blood (2023) 142 (Supplement 1): 359.

https://doi.org/10.1182/blood-2023-180607

Published: 2023

Journal Articles

A Novel Composite Endpoint of Toxicity- and Progression-Free Survival after B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma

Blood (2023) 142 (Supplement 1): 3336.

https://doi.org/10.1182/blood-2023-184406

Published: 2023

Journal Articles

Evaluation of Atrial Fibrillation Risk and Outcome after Allogeneic Transplantation Using an Artificial Intelligence ECG Algorithm and Echocardiographic Parameters in an MDS Cohort

Mario Ballerini, Michael Heckman, Launia White, Razan Mohty, Yenny Vanegas Moreno, Hassan Alkhateeb, Mohamed A. Kharfan-Dabaja, Nandita Khera, William J. Hogan, Mark R. Litzow, Abhishek A Mangaonkar, Hemant S. Murthy, Jeanne Palmer, Mithun V Shah, Lisa Sproat, Chris Ray, James M. Foran

Blood (2023) 142 (Supplement 1): 2287.

https://doi.org/10.1182/blood-2023-183019

Published: 2023

Journal Articles

A Multicenter Analysis of Allogeneic Transplant Outcomes in Patients with Philadelphia-like (Ph-like) Acute Lymphoblastic Leukemia (ALL)

Blood (2023) 142 (Supplement 1): 656.

https://doi.org/10.1182/blood-2023-178150

Published: 2023

Journal Articles

A Novel Composite Endpoint of Toxicity-Free, Progression-Free Survival (TPFS) after CD19-Directed Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma

Blood (2023) 142 (Supplement 1): 1776.

https://doi.org/10.1182/blood-2023-185117

Published: 2023

Journal Articles

Conditioning Regimen Intensity and Donor Choice Do Not Impact Outcomes of Patients (pts) with Acute Myeloid Leukemia (AML) after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) in First Complete Remission (CR1): An EBMT Analysis

Blood (2022) 140 (Supplement 1): 4876–4877.

https://doi.org/10.1182/blood-2022-165606

Published: 2022

Journal Articles

IPSS-Molecular but Not Individual Mutations Predicts Outcomes of Patients with Myelodysplastic Syndrome (MDS) after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT): A Mayo Clinic Cohort

Razan Mohty, Yenny Moreno Vanegas, Michael G. Heckman, Hassan B. Alkhateeb, Alexander P. Hochwald, William J. Hogan, Mohamed A. Kharfan-Dabaja, Rhett P. Ketterling, Nandita Khera, Mark R. Litzow, Abhishek A. Mangaonkar, Hemant S. Murthy, Jeanne M. Palmer, Mithun V. Shah, Lisa Z. Sproat, David S. Viswanatha, James M. Foran

Blood (2022) 140 (Supplement 1): 4863–4864.

https://doi.org/10.1182/blood-2022-168053

Published: 2022

Journal Articles

The CAR-Hematotox Score Identifies Patients at High Risk for Hematological Toxicity, Infections and Poor Clinical Outcomes Following Brexucabtagene Autoleucel in Relapsed/Refractory Mantle Cell Lymphoma

Kai Rejeski, Yucai Wang, Omar Albanyan, Javier L Munoz, Pierre Sesques, Gloria Iacoboni, Lucía López Corral, Razan Mohty, Martin Dreyling, Frederick L. Locke, Pere Barba, Emmanuel Bachy, Yi Lin, Marion Subklewe, Michael D. Jain

Blood (2022) 140 (Supplement 1): 651–653.

https://doi.org/10.1182/blood-2022-167329

Published: 2022

Journal Articles

Isocitrate Dehydrogenase (IDH) 1 and 2 Mutation Is an Independent Predictor of Better Outcome in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Study of the ALWP of EBMT

Razan Mohty, Abdul Hamid Bazarbachi, Myriam Labopin, Jordi Esteve, Nicolaus Kröger, Jan J. Cornelissen, Didier Blaise, Gerard Socie, Sébastien Maury, Arnold Ganser, Jean-Henri Bourhis, Claude-Eric Bulabois, Ibrahim Yakoub-Agha, Stephanie Nguyen, Patrice Chevallier, Ali Bazarbachi, Arnon Nagler, Mohamad Mohty

Blood (2021) 138 (Supplement 1): 2920.

https://doi.org/10.1182/blood-2021-149794

Published: 2021

Journal Articles

Impact of Gut Mycobiota Composition on Outcomes after Allogeneic Hematopoietic Cell Transplantation

Florent Malard, MD PhD, Giorgia Battipaglia, MD, Béatrice Gaugler, PhD, Rémy Duléry, MD, Eolia Brissot, MD PhD, Tounes Ledraa, MD, Razan Mohty, MD, Harry Sokol, MD PhD, Mohamad Mohty, MD PhD

Blood (2019) 134 (Supplement_1): 194.

https://doi.org/10.1182/blood-2019-122256

Published: 2019

Journal Articles

Investigating Antibiotic Exposure and Risk of Severe Acute Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Razan Mohty, MD, Remy Dulery, MD, Giorgia Battipaglia, MD, Eolia Brissot, MD PhD, Clemence Mediavilla, MD, Simona Sestili, MD, Tounes Ledraa, MD, Béatrice Gaugler, PhD, Agnès Bonnin, Mohamad Mohty, MD PhD, Florent Malard, MD PhD

Blood (2019) 134 (Supplement_1): 4539.

https://doi.org/10.1182/blood-2019-125213

Published: 2019

Journal Articles

Risk Adapted Therapeutic Strategy of Acute Myeloid Leukemia

Razan Mohty, MD, Radwan Massoud, BS, MD, Zaher Chakhachiro, MD, Rami Mahfouz, MD, Samer Nassif, MD, Jean Elcheikh, MD, Ali Bazarbachi, MD PhD

Blood (2019) 134 (Supplement_1): 3860.

https://doi.org/10.1182/blood-2019-125237

Published: 2019

Journal Articles

Achievement of High Concentration of Cyclosporine-a Is Associated with a Low Incidence of Acute Graft-Versus-Host Disease after Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Graft

Nicolas Stocker, MD, Remy Duléry, MD, Clemence Mediavilla, MD, Eolia Brissot, MD PhD, Giorgia Battipaglia, MD, Simona Sestili, MD, Annalisa Ruggeri, MD, Razan Mohty, Mohamad Mohty, MD PhD, Florent Malard, MD PhD

Blood (2018) 132 (Supplement 1): 4565.

https://doi.org/10.1182/blood-2018-99-111406

Published: 2018

Journal Articles

A Delayed Innate T Cell Reconstitution Is Associated with Epstein-Barr Virus Reactivation after Haploidentical Hematopoietic Stem Cell Transplantation Using Anti-Thymoglobulin and High-Dose Post-Transplant Cyclophosphamide

Nicolas Stocker, MD, Agathe Farge, MD, Laure Ricard, MD, Vincent Jachiet, MD, Clemence Mediavilla, MD, Eolia Brissot, MD PhD, Giorgia Battipaglia, MD, Remy Duléry, MD, Simona Sestili, MD, Annalisa Ruggeri, MD, Razan Mohty, Mohamad Mohty, MD PhD, Béatrice Gaugler, PhD, Florent Malard, MD PhD

Blood (2018) 132 (Supplement 1): 3398.

https://doi.org/10.1182/blood-2018-99-111449

Published: 2018

Journal Articles

Hematopoietic Recovery and Transfusion Needs after Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Adult Patients with Hematologic Malignancies

Razan Mohty, Florent Malard, MD PhD, Annalisa Ruggeri, MD, Eolia Brissot, MD PhD, Remy Dulery, MD, Giorgia Battipaglia, MD, Frederica Giannotti, MD, Simona Sestili, MD, Clemence Mediavilla, MD, Mohamad Mohty, MD PhD

Blood (2018) 132 (Supplement 1): 2109.

https://doi.org/10.1182/blood-2018-99-119516

Published: 2018

Journal Articles

Evaluation of Infectious Complications after Haploidentical Stem Cell Transplantation in Adult Patients with Hematologic Malignancies

Razan Mohty, Florent Malard, MDPhD, Annalisa Ruggeri, MD, Eolia Brissot, MDPhD, Remy Duléry, MD, Giorgia Battipaglia, MD, Frederica Giannotti, MD, Mohamad Mohty, MD PhD

Blood (2017) 130 (Supplement 1): 664.

https://doi.org/10.1182/blood.V130.Suppl_1.664.664

Published: 2017

NARROW

Hematopoietic Cell Transplantation (HCT) Is an Effective Treatment for Blastic Plasmacytoid Dendritic Cell Neoplasm: Systematic Review and Meta-Analysis Assessing the Role of Allogeneic and Autologous HCT

Outcomes and Clinical Characteristics of Adult Patients with Transplant Associated Thrombotic Microangiopathy: A Single Center Experience

Superior Survival with Intensive Chemotherapy, Compared to Hypomethylating Agent + Venetoclax, in Patients with Intermediate/Adverse Risk Acute Myeloid Leukemia Unable to Proceed to Transplant

Effect of Lumbar Puncture Timing on Neurotoxicity with Blinatumomab Therapy in a Real-World Cohort of Acute Lymphoblastic Leukemia (ALL)

Applying the Novel EHA/EBMT Grading System for Icaht Following CAR-T Therapy: Comparative Incidence across Disease Entities and Association with Infections and Mortality

A Novel Composite Endpoint of Toxicity- and Progression-Free Survival after B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma

Evaluation of Atrial Fibrillation Risk and Outcome after Allogeneic Transplantation Using an Artificial Intelligence ECG Algorithm and Echocardiographic Parameters in an MDS Cohort

A Multicenter Analysis of Allogeneic Transplant Outcomes in Patients with Philadelphia-like (Ph-like) Acute Lymphoblastic Leukemia (ALL)

A Novel Composite Endpoint of Toxicity-Free, Progression-Free Survival (TPFS) after CD19-Directed Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma

Conditioning Regimen Intensity and Donor Choice Do Not Impact Outcomes of Patients (pts) with Acute Myeloid Leukemia (AML) after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) in First Complete Remission (CR1): An EBMT Analysis

IPSS-Molecular but Not Individual Mutations Predicts Outcomes of Patients with Myelodysplastic Syndrome (MDS) after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT): A Mayo Clinic Cohort

The CAR-Hematotox Score Identifies Patients at High Risk for Hematological Toxicity, Infections and Poor Clinical Outcomes Following Brexucabtagene Autoleucel in Relapsed/Refractory Mantle Cell Lymphoma

Isocitrate Dehydrogenase (IDH) 1 and 2 Mutation Is an Independent Predictor of Better Outcome in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Study of the ALWP of EBMT

Impact of Gut Mycobiota Composition on Outcomes after Allogeneic Hematopoietic Cell Transplantation

Investigating Antibiotic Exposure and Risk of Severe Acute Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Risk Adapted Therapeutic Strategy of Acute Myeloid Leukemia

Achievement of High Concentration of Cyclosporine-a Is Associated with a Low Incidence of Acute Graft-Versus-Host Disease after Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Graft

A Delayed Innate T Cell Reconstitution Is Associated with Epstein-Barr Virus Reactivation after Haploidentical Hematopoietic Stem Cell Transplantation Using Anti-Thymoglobulin and High-Dose Post-Transplant Cyclophosphamide

Hematopoietic Recovery and Transfusion Needs after Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Adult Patients with Hematologic Malignancies

Evaluation of Infectious Complications after Haploidentical Stem Cell Transplantation in Adult Patients with Hematologic Malignancies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only